Amaryl
Amaryl

0.7
A generic medicine indicated for diabetes. Promotes insulin release from the pancreas to lower and stabilise blood glucose levels.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Glimepiride
Reference Brand
Glimepiride
Product Origin
Generic Alternative
Reference Manufacturer
Sanofi-Aventis
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
Sulfonylurea
Pharmacological Class
Second-Generation Sulfonylurea
Clinical Indications
Manufacturer Description
Indicated to address blood sugar levels to manage diabetes symptoms and alleviate glycemic fluctuations.
Mechanism of Action
Stimulates the release of insulin from functioning pancreatic beta cells by binding to specific ATP-sensitive potassium channels.
Route of Administration
Oral
Onset Time
2–3 hours
Duration
24 hours
Contraindications
Diabetic ketoacidosis, Severe hepatic impairment, Hypersensitivity to glimepiride
Severe Adverse Events
Severe hypoglycemia — requires immediate medical attention, Hemolytic anemia — requires immediate medical attention
Common Side Effects
Nausea, Dizziness, Headache
Uncommon Side Effects
Hypoglycemia, Weight gain, Flu-like symptoms
Drug Interactions
NSAIDs, Warfarin, Beta Blockers
Pregnancy Safety Warnings
TGA Category C: Risk of neonatal hypoglycemia. Avoid in late pregnancy. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Amaryl is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy NSAID Tablets - Buy Diclofenac AU